This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.
HIV Infections, Age
This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.
Vaccine Immunity and Inflammation in the Aging Person Living With HIV
-
Hennepin Healthcare System, Minneapolis, Minnesota, United States, 55415
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 95 Years
ALL
Yes
Hennepin Healthcare Research Institute,
2030-12-14